5 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Viracta Competitors or Alternatives

Viracta's top competitors include Atara, Tessa and AlloVir.

Unlock 17 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Viracta's company profile

Mark Rothera

President & CEO

90/100
20
$206.7M
$ < 1M
  • $206.7M
    $ < 1M
  • 20
    $206.7M
  • $ < 1M
  • 90/100
  • 20
  • $206.7M
  • $ < 1M
View ProfileView
1
Viracta's Competitor - Atara logo

Pascal Touchon

President & CEO

90/100
330
$111.7M
$23.1M
  • $111.7M
    $23.1M
  • 330
    $111.7M
  • $23.1M
  • 90/100
  • 330
  • $111.7M
  • $23.1M
View ProfileView
2
Viracta's Competitor - Tessa logo

Thomas Willemsen

CEO

90/100
100 - 250
$256M
$5M - 25M
  • $256M
    $5M - 25M
  • 100 - 250
    $256M
  • $5M - 25M
  • 90/100
  • 100 - 250
  • $256M
  • $5M - 25M
View ProfileView
3
Viracta's Competitor - AlloVir logo

Vikas Sinha

CEO

82/100
20
$658.2M
$ < 1M
  • $658.2M
    $ < 1M
  • 20
    $658.2M
  • $ < 1M
  • 82/100
  • 20
  • $658.2M
  • $ < 1M
View ProfileView
4
Viracta's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$103.9M
  • $821.4M
    $103.9M
  • 520
    $821.4M
  • $103.9M
  • 73/100
  • 520
  • $821.4M
  • $103.9M
View ProfileView
5
Viracta's Competitor - Inovio logo

Jacqueline Shea

President & CEO

47/100
320
$296.4M
$ < 1M
  • $296.4M
    $ < 1M
  • 320
    $296.4M
  • $ < 1M
  • 47/100
  • 320
  • $296.4M
  • $ < 1M
View ProfileView
Viracta's top 20 competitors are Atara, Tessa, AlloVir, Kite Pharma, bluebird bio, Inovio, VBI, Agenus, Dynavax, Immune Design, CytImmune, Juno Therapeutics, Advaxis, Vir, Arbutus Biopharma, Sinovac, Zynerba, Merrimack, Peloton Therapeutics and Novartis. Together they have raised over 19.4B between their estimated 86.2K employees. Viracta has 20 employees and is ranked 18th among it's top 10 competitors. The top 10 competitors average 4,105.

Viracta VS Atara

Atara is one of Viracta's top competitors. Atara was founded in 2012 in South San Francisco, California. Like Viracta, Atara also operates in the Pharmaceuticals & Biotechnology industry. Atara generates $23.1M more revenue than Viracta.

Viracta VS Tessa

Tessa is a top competitor of Viracta. Tessa was founded in 2012, and is headquartered in Singapore, Central Singapore. Like Viracta, Tessa also competes in the Biotechnology field. Tessa generates $6.7M more revenue vs. Viracta.

Viracta VS AlloVir

AlloVir is seen as one of Viracta's top competitors. AlloVir is headquartered in Lexington, Massachusetts, and was founded in 2013. Like Viracta, AlloVir also operates in the Biotechnology field. AlloVir generates ∞% the revenue of Viracta.

Looking for similar companies to Viracta?

Similar Companies

Biotechnology companies in Cardiff

See 16 companies 
Companies in Cardiff with employees in 25-100 range

See 464 companies 
Pharmaceuticals & Biotechnology companies in Cardiff

See 24 companies 
Biotechnology companies in San Diego County

See 693 companies 
Pharmaceuticals & Biotechnology companies in San Diego County

See 909 companies 
Biotechnology companies in California

See 3,106 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,199 companies 
Biotechnology companies with employees in 25-100 range

See 5,172 companies 
Pharmaceuticals & Biotechnology companies with employees in 25-100 range

See 7,091 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Viracta and Viracta's Competitors

July 20, 2026BioSpace
The FDA is currently reviewing Vertex Pharmaceuticals' povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from cam...
July 20, 2026Ad-hoc-news
Novartis AG CH0012005267 - Forscherin pipettiert präzise in steriler Pharmalaborumgebung mit Reagenzgläsern, Illustration mit AI erstellt. Novartis AG ...
July 20, 2026Mediatrainingforceos
The cancer therapy market is estimated to be valued at USD 260.52 Bn in 2026 and is expected to reach USD 605.35 Bn by 2033. BURLINGAME, CA, UNITED STA...
July 19, 2026Ad-hoc-news
Novartis AG CH0012005267 - Börsentafel mit Pharmacharts und Händlern auf belebtem Schweizer Trading-Floor, Illustration mit AI erstellt. Novartis stock...

Frequently Asked Questions about Viracta

  1. Who are Viracta's top competitors?

    Viracta's top 3 competitors are Atara, Tessa, AlloVir.

  2. Who is similar to Viracta?

    Atara is the most similar to Viracta. Tessa and AlloVir are also similar to Viracta.

  1. Are Viracta and Atara competitors?

    Yes, Atara is one of Viracta’s top competitors.